James W. Brady, Jr. is in his 28th year of practice. He joined Dickstein Shapiro in 1988 and is a partner in the Intellectual Property Practice. He focuses on patent litigation, United States Patent and Trademark Office post issuance procedures, patent acquisition, opinions, and intellectual property monetization. Mr. Brady has served as lead intellectual property counsel to a wide range of chemical, pharmaceutical, biotechnology, and medical device clients. He has successfully represented clients in litigation (obtaining judgments totaling approximately 1.1 billion dollars in 2008 and 2011), business transactions, and developing strategies to position the companies and their intellectual property portfolios to succeed in highly competitive industries. His technical knowledge and facility for marshaling complex scientific facts and principles encompasses polymers, pharmaceuticals, drug delivery, diagnostics, antibodies, vaccines, genomics, proteomics, medical devices, and environmental processes, among others.
